Published in Comp Biochem Physiol B on November 01, 1993
Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J (1987) 4.56
Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature (1985) 3.97
Comparison of human stromelysin and collagenase by cloning and sequence analysis. Biochem J (1986) 3.31
Stimulation by endocytosis of the secretion of collagenase and neutral proteinase from rabbit synovial fibroblasts. J Exp Med (1974) 2.36
Evidence that latent collagenases are enzyme-inhibitor complexes. Biochem J (1977) 2.32
Purification and characterization of a rabbit bone metalloproteinase that degrades proteoglycan and other connective-tissue components. Biochem J (1983) 2.17
Purification of rabbit bone inhibitor of collagenase. Biochem J (1981) 2.12
Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase. Biochem J (1989) 1.89
Biosynthesis of tissue inhibitor of metalloproteinases by human fibroblasts in culture. Stimulation by 12-O-tetradecanoylphorbol 13-acetate and interleukin 1 in parallel with collagenase. J Biol Chem (1985) 1.86
Electrical activity observed in guinea-pig olfactory cortex maintained in vitro. J Physiol (1968) 1.83
On the mechanism of barbiturate anaesthesia. J Physiol (1972) 1.75
IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion. J Clin Invest (2000) 1.74
Immunolocalization of tissue inhibitor of metalloproteinases (TIMP) in human cells. Characterization and use of a specific antiserum. J Cell Sci (1985) 1.73
Calcium, magnesium and the electrical activity of guinea-pig olfactory coex in vitro. J Physiol (1970) 1.72
The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor. Biochem J (1983) 1.72
Degenerate perturbations of protein structure as the mechanism of anaesthetic action. Nature (1979) 1.68
Partial purification of collagenase and gelatinase from human polymorphonuclear leucocytes. Analysis of their actions on soluble and insoluble collagens. Biochem J (1982) 1.66
The latent collagenase and gelatinase of human polymorphonuclear neutrophil leucocytes. Biochem J (1980) 1.64
Metalloproteinases from rabbit bone culture medium degrade types IV and V collagens, laminin and fibronectin. Biochem J (1981) 1.62
Neutral metallo-proteinases of rabbit bone. Separation in latent forms of distinct enzymes that when activated degrade collagen, gelatin and proteoglycans. Biochem J (1978) 1.60
Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells. Br J Cancer (1993) 1.60
The detection and characterisation of collagenase inhibitors from rabbit tissues in culture. Biochim Biophys Acta (1977) 1.57
Purification and characterization of a bone metalloproteinase that degrades gelatin and types IV and V collagen. Biochim Biophys Acta (1985) 1.56
Collagenase is a component of the specific granules of human neutrophil leucocytes. Biochem J (1977) 1.55
An inhibitor of collagenase from human amniotic fluid. Purification, characterization and action on metalloproteinases. Biochem J (1981) 1.52
Anaesthetics depress the sensitivity of cortical neurones to L-glutamate. Br J Pharmacol (1976) 1.51
Characterization of a specific antiserum to rabbit stromelysin and demonstration of the synthesis of collagenase and stromelysin by stimulated rabbit articular chondrocytes. Coll Relat Res (1986) 1.50
The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann N Y Acad Sci (1992) 1.48
An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat. Neuroscience (1998) 1.47
Origin of plasma alpha2HS-glycoprotein and its accumulation in bone. Nature (1976) 1.41
Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J Biol Chem (1995) 1.41
Binding of gelatinases A and B to type-I collagen and other matrix components. Biochem J (1995) 1.41
The expression of full length Gp91-phox protein is associated with reduced amphotropic retroviral production. Haematologica (2000) 1.40
Cytochalasin B increases collagenase production by cells in vitro. Nature (1975) 1.40
CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells (1998) 1.40
A new factor that may control collagen resorption. Lancet (1977) 1.38
Pyrophosphate stimulation of calcium uptake into cultured embryonic bones. Fine structure of matrix vesicles and their role in calcification. Dev Biol (1973) 1.37
Overexpression of active TGF-beta-1 in the murine knee joint: evidence for synovial-layer-dependent chondro-osteophyte formation. Osteoarthritis Cartilage (2001) 1.36
Anchorage-independent colony growth of pulmonary fibroblasts derived from fibrotic human lung tissue. J Clin Invest (1994) 1.35
Secretion of 72 kDa type IV collagenase/gelatinase by cultured human lipocytes. Analysis of gene expression, protein synthesis and proteinase activity. Biochem J (1992) 1.35
Potentiation and depression of synaptic transmission in the olfactory cortex of the guinea-pig. J Physiol (1972) 1.35
A novel method for absolute calibration of intracellular pH indicators. Pflugers Arch (1989) 1.35
Inhibition by calcitonin of bone resorption induced in vitro by vitamin A. Proc R Soc Lond B Biol Sci (1968) 1.35
The origin of matrix metalloproteinases and their familial relationships. FEBS Lett (1991) 1.34
Identification and partial characterization of an inhibitor of collagenase from rabbit bone. Biochem J (1977) 1.34
Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction. J Immunol (1999) 1.32
Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3. Biochem J (1998) 1.29
Rabbit bone collagenase inhibitor blocks the activity of other neutral metalloproteinases. Biochem Biophys Res Commun (1979) 1.29
Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes. Biochim Biophys Acta (1991) 1.28
Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis. Ann Rheum Dis (1995) 1.27
Binding of latent and high Mr active forms of stromelysin to collagen is mediated by the C-terminal domain. J Cell Sci (1991) 1.26
Purification and characterization of human 72-kDa gelatinase (type IV collagenase). Use of immunolocalisation to demonstrate the non-coordinate regulation of the 72-kDa and 95-kDa gelatinases by human fibroblasts. Biol Chem Hoppe Seyler (1991) 1.24
Characterization of a specific antiserum for mammalian collagenase from several species: immunolocalization of collagenase in rabbit chondrocytes and uterus. J Cell Sci (1986) 1.22
Alkylpurine-DNA-N-glycosylase knockout mice show increased susceptibility to induction of mutations by methyl methanesulfonate. Mol Cell Biol (1998) 1.21
Na+/H+ exchange is the major mechanism of pH regulation in cultured sympathetic neurons: measurements in single cell bodies and neurites using a fluorescent pH indicator. Neuroscience (1987) 1.20
Interleukins 4 and 13 increase intestinal epithelial permeability by a phosphatidylinositol 3-kinase pathway. Lack of evidence for STAT 6 involvement. J Biol Chem (2000) 1.19
Metalloproteinases and tissue damage. Br J Rheumatol (1991) 1.18
Levels of the DNA repair enzyme human apurinic/apyrimidinic endonuclease (APE1, APEX, Ref-1) are associated with the intrinsic radiosensitivity of cervical cancers. Br J Cancer (1998) 1.15
Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo. Arthritis Rheum (2003) 1.15
Pig interleukin 1 (catabolin) is a potent stimulator of bone resorption in vitro. Calcif Tissue Int (1985) 1.13
The action of ether and methoxyflurane on synaptic transmission in isolated preparations of the mammalian cortex. J Physiol (1975) 1.13
Electrical activity observed in guinea-pig olfactory cortex maintained in vitro and its modification by changes in the ionic composition of the bathing medium. J Physiol (1968) 1.13
Mouse osteoblasts synthesize collagenase in response to bone resorbing agents. Biochim Biophys Acta (1984) 1.13
Metalloproteinase inhibitors from bovine cartilage and body fluids. Eur J Biochem (1984) 1.13
Immunochemical studies with a specific antiserum to rabbit fibroblast collagenase. Biochem J (1975) 1.11
Immunolocalization of metalloproteinases and their inhibitor in the rabbit growth plate. J Bone Joint Surg Am (1989) 1.11
Inhibition of type I collagen film degradation by tumour cells using a specific antibody to collagenase and the specific tissue inhibitor of metalloproteinases (TIMP). Cell Biol Int Rep (1985) 1.10
Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: implications for cartilage degradation in arthritis. Arthritis Rheum (2006) 1.10
Gelatinase (type IV collagenase) immunolocalization in cells and tissues: use of an antiserum to rabbit bone gelatinase that identifies high and low Mr forms. J Cell Sci (1989) 1.10
Purification and properties of a specific collagenase from rabbit synovial fibroblasts. Biochem J (1975) 1.10
The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts. J Cell Sci (1994) 1.10
Characterisation of the calcium responses to histamine in capsaicin-sensitive and capsaicin-insensitive sensory neurones. Neuroscience (2002) 1.09
The effect of bilayer thickness and n-alkanes on the activity of the (Ca2+ + Mg2+)-dependent ATPase of sarcoplasmic reticulum. J Biol Chem (1981) 1.09
The actions of volatile anaesthetics on synaptic transmission in the dentate gyrus. J Physiol (1975) 1.08
The effect of two diphosphonates on the resorption of mouse calvaria in vitro. Calcif Tissue Res (1972) 1.07
Intra-articular IL-10 gene transfer regulates the expression of collagen-induced arthritis (CIA) in the knee and ipsilateral paw. Clin Exp Immunol (2000) 1.07
Changes in free-calcium levels and pH in synaptosomes during transmitter release. Biochim Biophys Acta (1984) 1.06
Specific release of endogenous glutamate from piriform cortex stimulated in vitro. Brain Res (1976) 1.06
Inhibition of bone resorption by selective inactivators of cysteine proteinases. J Cell Biochem (1994) 1.06
Human gingival tissues in culture synthesize three metalloproteinases and a metalloproteinase inhibitor. J Periodontal Res (1982) 1.06
On the mechanism of halothane anaesthesia. J Physiol (1973) 1.06
Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines. J Cell Sci (1992) 1.04
Interleukin-1 in combination with oncostatin M up-regulates multiple genes in chondrocytes: implications for cartilage destruction and repair. Arthritis Rheum (2006) 1.04
Characterization of collagenase, other metallo-proteinases and an inhibitor (TIMP) produced by human synovium and cartilage in culture. Clin Sci (Lond) (1981) 1.04
Inactivation of O6-alkylguanine-DNA alkyltransferase. 1. Novel O6-(hetarylmethyl)guanines having basic rings in the side chain. J Med Chem (1998) 1.03
The effect of ascorbic acid on the growth of chick bone rudiments in chemically defined medium. Exp Cell Res (1966) 1.03
Production of collagenase and inhibitor (TIMP) by normal, rheumatoid and osteoarthritic synovium in vitro: effects of hydrocortisone and indomethacin. Clin Sci (Lond) (1981) 1.03
Advances in understanding cell interactions in tissue resorption. Relevance to the pathogenesis of periodontal diseases and a new hypothesis. J Oral Pathol (1986) 1.03
Outpatient drug abuse treatment services, 1988: results of a national survey. NIDA Res Monogr (1991) 1.03
Actions of general anaesthetics on synaptic transmission in the CNS. Br J Anaesth (1983) 1.01
Chloride fluxes in crab muscle fibres. J Physiol (1969) 1.01
Direct monitoring of dopamine and 5-HT release in substantia nigra and ventral tegmental area in vitro. Exp Brain Res (1994) 1.00
Identification of the cross-link between human O6-methylguanine-DNA methyltransferase and chloroethylnitrosourea-treated DNA. Cancer Res (1992) 1.00
Construction of recombinant human type 5 adenoviruses expressing rodent IL-6 genes. An approach to investigate in vivo cytokine function. J Immunol (1993) 1.00
Long-term potentiation at excitatory amino acid synapses on midbrain dopamine neurons. Neuroreport (1999) 1.00
Additive and non-additive effects of mixtures of short-acting intravenous anaesthetic agents and their significance for theories of anaesthesia. Br J Pharmacol (1981) 1.00
Oncostatin M stimulates monocyte chemoattractant protein-1- and interleukin-1-induced matrix metalloproteinase-1 production by human synovial fibroblasts in vitro. Arthritis Rheum (1997) 1.00
The action of anaesthetics on synaptic transmission. Gen Pharmacol (1978) 1.00
Isolation and cDNA cloning of a rat O6-alkylguanine-DNA-alkyltransferase gene, molecular analysis of expression in rat liver. Carcinogenesis (1991) 0.99